ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility ...

Report on how AI is driving market transformation - The global fetal bovine serum market size is estimated to grow by USD 364.2 million from 2025-2029, according to Technavio. The market is estimated ...

Canyon Labs, a global provider of analytical and packaging lab testing and consulting for medical devices and pharmaceuticals, and iuvo BioScience, a full service provider of ophthalmic medical device ...

Cipla is a leading pharmaceutical from India with presence across the world. It was established in 1935 as Chemical Industrial & Pharmaceutical Laboratories Ltd and changed to its current name in 1984 ...

Laboratory of Pharmaceutical Crystal Engineering & Technology, East China University of Science and Technology No. 130 Meilong Road, Shanghai 200237, China State Key Laboratory of Bioreactor ...

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China Department of Applied Biology, East China University of Science and ...

(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...